ASP Isotopes Inc (ASPI) USD0.01

Sell:$4.80Buy:$4.92$0.13 (2.77%)

Prices delayed by at least 15 minutes
Sell:$4.80
Buy:$4.92
Change:$0.13 (2.77%)
Prices delayed by at least 15 minutes
Sell:$4.80
Buy:$4.92
Change:$0.13 (2.77%)
Prices delayed by at least 15 minutes

Company Information

About this company

ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.

Key people

Paul Elliot Mann
Executive Chairman of the Board, Chief Executive Officer
Heather Kiessling
Chief Financial Officer
Robert Ainscow
Chief Operating Officer
Hendrik Strydom
Chief Technology Officer, Director
Michael Gorley
Independent Director
Duncan Moore
Independent Director
Robert Ryan
Independent Director
Todd Wider
Independent Director
Click to see more

Key facts

  • EPIC
    ASPI
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US00218A1051
  • Market cap
    $298.77m
  • Employees
    76
  • Shares in issue
    72.07m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.